NeuroPace (NPCE) Equity Ratio (2020 - 2026)

NeuroPace's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.15 for Q1 2026.

• In Q1 2026, Equity Ratio fell 33.63% year-over-year to 0.15; the TTM figure through Mar 2026 stood at 0.15 (down 33.63% YoY), while the FY2025 annual figure was 0.18, up 112.94% from the prior year.
• Equity Ratio was 0.15 for Q1 2026 at NeuroPace, down from 0.18 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.49 in Q1 2022 to a low of 0.08 in Q4 2024.
• Historically, Equity Ratio has averaged 0.22 across 5 years, with a median of 0.18 in 2025.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio soared 115.67% in 2022, then tumbled 55.87% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.3 in 2022, then tumbled by 37.05% to 0.19 in 2023, then tumbled by 55.87% to 0.08 in 2024, then jumped by 112.94% to 0.18 in 2025, then fell by 18.93% to 0.15 in 2026.
• The last three Equity Ratio figures came in at 0.15 (Q1 2026), 0.18 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.